- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04273035
Handheld-multimedia Versus Oral Midazolam in Pediatric on Perioperative Anxiety
The Effect of Handheld-multimedia Versus Oral Midazolam Preanesthetic on the Level of Perioperative Anxiety in Pediatric Day-care Surgery: A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Perioperative anxiety in children is a common multifactorial influenced and triggered entity with an incidence as high as 50%. Especially (mask)induction of anesthesia is considered one of the most stressful experiences for a child undergoing surgery. A common practice worldwide to diminish the level of anxiety prior to anesthesia is premedication with the benzodiazepine midazolam in order to improve cooperation during induction.
Premedication with midazolam has a primary purpose to reduce preoperative anxiety and has inherent to a benzodiazepine its sedative effects. Although these effects are implied, negative effects of premedication: respiratory complications, paradoxical negative behavior has been reported. Although alternative medications have been studied, studies for non-pharmacological anxiety-reduction remain limited.
Non-pharmacological anxiety-reduction by distraction including Tablet or IPAD-multimedia might be a readily available alternative for midazolam premedication. Potentially limiting the use of psychoactive agents, limiting the need for preoperative sedation and therefore possibly decrease secondary respiratory complications in pediatric surgical day-care.
Objective:
The first goal of this study is to compare the efficacy and safety between anxiolysis by multimedia-distraction with an IPAD versus anxiolysis by premedication with midazolam prior to the mask-induction of anesthesia. Secondly to evaluate the need for midazolam premedication in pediatric day-care surgery patients induced by inhalational anesthesia.
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Alex Van Hoorn, MD
- Phone Number: +32468187852
- Email: Alex.VanHoorn@uzbrussel.be
Study Contact Backup
- Name: Panagiotis Flamée, MD
- Phone Number: +3224773143
- Email: Panagiotis.Flamee@uzbrussel.be
Study Locations
-
-
-
Jette, Belgium, 1090
- Recruiting
- Universitair Ziekenhuis Brussel (UZ Brussel)
-
Contact:
- Alex Van Hoorn, MD
- Phone Number: +324749232
- Email: Alex.VanHoorn@uzbrussel.be
-
Contact:
- Pangiotis Flamée, MD
- Phone Number: +324773143
- Email: Panagiotis.Flamee@uzbrussel.be
-
Principal Investigator:
- Alex Van Hoorn, MD
-
Principal Investigator:
- Pangiotis Flamée, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion criteria
- Age ≥ 1 year and <8 years old
- ASA class 1 or 2 (American Society of Anesthesiologists Physical Status Classification System)
- Elective circumcision, tonsillectomy or adenoidectomy, dental care procedure in day-care
- Written informed consent by the legal parents or caretaker
Exclusion criteria
- Parents of the patient wish not to participate with the study
- Parents are not able to give informed consent (language barrier, legally incapable)
- A contraindication for the use of premedication with midazolam
- A known allergy to midazolam
- A contraindication for premedication in general
- A contraindication for the use of a gas-induction/gas-anesthesia
- A contraindication for the use of sevoflurane
- A known mental retardation of the child
- Preoperative behavioral disturbances and psychiatric disorders
- Any use of psychoactive medication
- A known photosensitive epilepsy
- A previous operation within 3 months of the time of scheduled operation
- Any other contraindication for the use of the study medication
- Previous history of multiple surgery (>3)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Midazolam Group
|
Oral Buccolam
Other Names:
|
Active Comparator: IPAD group
|
Playing any game, film, clip or puzzle on a tablet till after induction of anesthesia
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety level at induction
Time Frame: Directly prior to induction of anesthesia, 20 minutes
|
Measured bij Short version modified Yale Preoperative Anxiety Scale(mYPAS-SF), scoring activity 1-4/4, vocalizations 1-6/6, emotional expressivity 1-4/4, state of apparent arousal 1-4/4, parental use 1-4/4, subtotal is the sum of all the individual scores divided by their number of choices, mYpas-SF total score is subtotal/5 * 100 and therefore a score between 23,3-100 Scored prior moment of mask induction (T2)
|
Directly prior to induction of anesthesia, 20 minutes
|
Anesthesiologist Satisfaction Induction
Time Frame: During induction of anesthesia 10 minutes
|
Satisfactory Score for Induction/Anesthesia: 5 point scale: Very satisfactory, Satisfactory, Neutral, Unsatisfactory and Very satisfactory Scored in the OR directly post induction
|
During induction of anesthesia 10 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety level at Daycare
Time Frame: Leaving daycare, 10 minutes
|
Measured bij Short version modified Yale Preoperative Anxiety Scale(mYPAS-SF), scoring activity 1-4/4, vocalizations 1-6/6, emotional expressivity 1-4/4, state of apparent arousal 1-4/4, parental use 1-4/4, subtotal is the sum of all the individual scores divided by their number of choices, mYpas-SF total score is subtotal/5 * 100 and therefore a score between 23,3-100 Scored at Daycare (T0) when leaving to holding
|
Leaving daycare, 10 minutes
|
Anxiety level at holding
Time Frame: On holding, 20 minutes
|
Measured bij Short version modified Yale Preoperative Anxiety Scale(mYPAS-SF), scoring activity 1-4/4, vocalizations 1-6/6, emotional expressivity 1-4/4, state of apparent arousal 1-4/4, parental use 1-4/4, subtotal is the sum of all the individual scores divided by their number of choices, mYpas-SF total score is subtotal/5 * 100 and therefore a score between 23,3-100 Scored at holding (T1) 10 minutes after arrival
|
On holding, 20 minutes
|
Anxiety level at recovery
Time Frame: 15 minutes after awake, 30 minutes
|
Measured bij Short version modified Yale Preoperative Anxiety Scale(mYPAS-SF), scoring activity 1-4/4, vocalizations 1-6/6, emotional expressivity 1-4/4, state of apparent arousal 1-4/4, parental use 1-4/4, subtotal is the sum of all the individual scores divided by their number of choices, mYpas-SF total score is subtotal/5 * 100 and therefore a score between 23,3-100 Scored at recovery (T3) 15 minutes after awake
|
15 minutes after awake, 30 minutes
|
Anxiety level Change Daycare vs OR
Time Frame: change during daycare (T0) and induction(T2) in the OR, average 1 hour
|
Measured bij Short version modified Yale Preoperative Anxiety Scale(mYPAS-SF), scoring activity 1-4/4, vocalizations 1-6/6, emotional expressivity 1-4/4, state of apparent arousal 1-4/4, parental use 1-4/4, subtotal is the sum of all the individual scores divided by their number of choices, mYpas-SF total score is subtotal/4 * 100 and therefore a score between 23,3-100
|
change during daycare (T0) and induction(T2) in the OR, average 1 hour
|
Sedation level at Daycare
Time Frame: 10 minutes
|
Richmond Agitation-Sedation Scale, RASS-score between -5 till + 4 Scored at Daycare (T0) when leaving to holding
|
10 minutes
|
Sedation level at holding
Time Frame: 20 minutes
|
Richmond Agitation-Sedation Scale, RASS-score between -5 till + 4 Scored (T1) 10 minutes after arrival holding
|
20 minutes
|
Sedation level at induction
Time Frame: 10 minutes
|
Richmond Agitation-Sedation Scale, RASS-score between -5 till + 4 Scored at moment of mask induction (T2)
|
10 minutes
|
Sedation level at recovery
Time Frame: 30 minutes
|
Richmond Agitation-Sedation Scale, RASS-score between -5 till + 4 Scored 15 minutes after arrival recovery (T3)
|
30 minutes
|
Laryngospasm at induction
Time Frame: 10 minutes
|
Laryngospasm by Four-point scale:
|
10 minutes
|
Laryngospasm post extubation/post laryngeal mask
Time Frame: 10 minutes
|
Laryngospasm by Four-point scale:
|
10 minutes
|
Bronchospasm postinduction
Time Frame: 10 minutes
|
Bronchospasm/wheezing 1. Yes 2. No • In absence of scale Scored in the OR postinduction
|
10 minutes
|
Bronchospasm post detubation/laryngeal mask
Time Frame: 10 minutes
|
Bronchospasm/wheezing 1. Yes 2. No • In absence of scale Scored in the OR post detonation/laryngeal mask
|
10 minutes
|
Postoperative Pain
Time Frame: 40 minutes
|
The pain observation scale for young children (POCIS-Score) score 0-7, scoring 0 or1 for • face-expression: frowning/grimaces = 1, sound crying/moan =1, breathing: irregular/gasping/holding=1, body tonus: tense/shiver/restless =1, movement of arms: tense/fist/restless =1, movement of legs: tense/pulled up/flexed = 1, mood: agitation/restless = 1 Scored on the recovery 30 minutes after arrival
|
40 minutes
|
Parental Satisfaction on the anxiety-management at daycare
Time Frame: 10 minutes
|
|
10 minutes
|
Parental Satisfaction on the anxiety-management at holding
Time Frame: 10 minutes
|
|
10 minutes
|
Parental Satisfaction on the anxiety-management at OR
Time Frame: 10 minutes
|
|
10 minutes
|
Parental Satisfaction on the anxiety-management at recovery
Time Frame: 10 minutes
|
|
10 minutes
|
Parental Stress level at day care
Time Frame: 10 minutes
|
Parental Stress level in 5 - point scale- ´I feel':
|
10 minutes
|
Parental Stress level at holding
Time Frame: 10 minutes
|
Parental Stress level in 5 - point scale- ´I feel':
|
10 minutes
|
Parental Stress level at OR
Time Frame: 10 minutes
|
Parental Stress level in 5 - point scale- ´I feel':
|
10 minutes
|
Parental Stress level at recovery
Time Frame: 10 minutes
|
Parental Stress level in 5 - point scale- ´I feel':
|
10 minutes
|
Overall Parental Satisfaction
Time Frame: 10 minutes
|
5- Point scale
|
10 minutes
|
Child Stress level by parent at daycare
Time Frame: 10 minutes
|
Child Stress level by parent, 5- Point scale
|
10 minutes
|
Child Stress level by parent at holding
Time Frame: 10 minutes
|
Child Stress level by parent, 5- Point scale
|
10 minutes
|
Child Stress level by parent at OR
Time Frame: 10 minutes
|
Child Stress level by parent, 5- Point scale
|
10 minutes
|
Child Stress level by parent at Recovery
Time Frame: 10 minutes
|
Child Stress level by parent, 5- Point scale
|
10 minutes
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative need for pain medication
Time Frame: 1 hour
|
Postoperative need for pain medication, indicated as yes or no, and description of medication with given dose Noted on the recovery
|
1 hour
|
Postoperative need for anti-nausea/vomiting medication
Time Frame: 1 hour
|
Postoperative need for anti-nausea/vomiting medication, indicated as yes or no, and description of product with given dose Noted on the recovery
|
1 hour
|
Time arrival recovery to time leaving recovery
Time Frame: 2 hour
|
Time arrival recovery to time leaving recovery, time notation on arrival and leaving Noted on the recovery
|
2 hour
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alex Van Hoorn, MD, Resident of department of Anesthesiology
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Anxiety Disorders
- Physiological Effects of Drugs
- Neurotransmitter Agents
- Molecular Mechanisms of Pharmacological Action
- Central Nervous System Depressants
- Anesthetics, Intravenous
- Anesthetics, General
- Anesthetics
- Tranquilizing Agents
- Psychotropic Drugs
- Hypnotics and Sedatives
- Adjuvants, Anesthesia
- Anti-Anxiety Agents
- GABA Modulators
- GABA Agents
- Midazolam
Other Study ID Numbers
- 2019/318
- 2019-004671-39 (EudraCT Number)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
- Individual participant data will be available after deidentification
- For researchers who provide a methodological proposal
- Achieving aims in the proposal
- Proposals needs to be directed to the principal investigators
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- Study Protocol
- Statistical Analysis Plan (SAP)
- Informed Consent Form (ICF)
- Clinical Study Report (CSR)
- Analytic Code
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Tonsillectomy
-
Boston Children's HospitalTerminatedPost-tonsillectomy Pain | Post-tonsillectomy Activity | Post-tonsillectomy HydrationUnited States
-
IRCCS Burlo GarofoloRecruiting
-
Medtronic - MITGCompleted
-
University Children's Hospital BaselCompleted
-
Sarah KhanCompleted
-
Wayne State UniversityChildren's Hospital of Michigan FoundationUnknown
-
Centre Hospitalier Universitaire de BesanconCompleted
-
University of RegensburgMerck Sharp & Dohme LLCUnknown
Clinical Trials on Midazolam oral solution
-
NovaceaUnknownNon-Hodgkin's Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaUnited States
-
Crinetics Pharmaceuticals Inc.CompletedHealthy VolunteersAustralia
-
Cairo UniversityCompletedPreoperative SedationEgypt
-
Foresee Pharmaceuticals Co., Ltd.CompletedHealthy VolunteersAustralia
-
Crinetics Pharmaceuticals Inc.CompletedHealthy VolunteersAustralia
-
AlzProtect SASActive, not recruitingProgressive Supranuclear PalsyFrance
-
Crinetics Pharmaceuticals Inc.CompletedHealthy VolunteersUnited States
-
El Instituto Nacional de Neurologia y Neurocirugia...Recruiting
-
Emergent BioSolutionsNational Institute of Allergy and Infectious Diseases (NIAID)TerminatedViral InfectionUnited States